The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.83BCNY
874.45M · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
66.40x
vs Medical Devices peers
Updated Oct 24, 2026
Revenue (TTM)
589.57MCNY
88.42M · vs all stocks (USD)
Updated Oct 24, 2026
Profit Margin
14.21%
vs Medical Devices peers
Updated Oct 24, 2026
Beta
0.5950x
vs all stocks
Updated Oct 24, 2026
52-Week Change
-49.82%
vs all stocks
Updated Oct 24, 2026
Market Capitalization
5.83BCNY
874.45M · vs all stocks (USD)
Updated Oct 24, 2026
Enterprise Value
5.35BCNY
801.83M · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
66.40x
vs Medical Devices peers
Updated Oct 24, 2026
Forward P/E
55.72x
vs Medical Devices peers
Updated Oct 24, 2026
Price to Sales (TTM)
9.41x
vs Medical Devices peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 9.89×.Updated Oct 24, 2026
Price to Book (MRQ)
5.57x
vs Medical Devices peers
Updated Oct 24, 2026
Enterprise to Revenue
9.07x
vs Medical Devices peers
Updated Oct 24, 2026
Enterprise to EBITDA
33.54x
vs Medical Devices peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 34.93×.Updated Oct 24, 2026
Gross Margin
70.51%
vs Medical Devices peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 67.16%.Updated Oct 24, 2026
Profit Margin
14.21%
vs Medical Devices peers
Updated Oct 24, 2026
Operating Margin
20.86%
vs Medical Devices peers
Updated Oct 24, 2026
Return on Assets (TTM)
4.64%
vs Medical Devices peers
Updated Oct 24, 2026
Return on Equity (TTM)
9.00%
vs Medical Devices peers
Updated Oct 24, 2026
Revenue (TTM)
589.57MCNY
88.42M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue per Share (TTM)
1.44CNYUpdated Oct 24, 2026
Quarterly Revenue Growth
18.10%
vs Medical Devices peers
Updated Oct 24, 2026
Gross Profit (TTM)
395.93MCNY
59.38M · vs all stocks (USD)
Updated Oct 24, 2026
EBITDA (TTM)
153.07MCNY
22.96M · vs all stocks (USD)
Updated Oct 24, 2026
Net Income (TTM)
83.77MCNY
12.56M · vs all stocks (USD)
Updated Oct 24, 2026
Quarterly Earnings Growth (YoY)
137.90%
vs Medical Devices peers
Updated Oct 24, 2026
Operating Cash Flow (TTM)
203.58MCNY
30.53M · vs all stocks (USD)
Updated Oct 24, 2026
Levered Free Cash Flow (TTM)
92.22MCNY
13.83M · vs all stocks (USD)
Updated Oct 24, 2026
Payout Ratio
0.00%
vs Medical Devices peers
Updated Oct 24, 2026
Minority Interest (Equity)
32.18MCNYFY2025 · Dec 31, 2025
Revenue
525.41MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
176.98MCNYFY2025 · Dec 31, 2025
Gross Profit
348.42MCNYFY2025 · Dec 31, 2025
Operating Income
75.17MCNY
11.27M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
68.45MCNYFY2025 · Dec 31, 2025
Income Tax Expense
20.98MCNYFY2025 · Dec 31, 2025
Net Income
47.47MCNYFY2025 · Dec 31, 2025
EBIT
73.49MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
153.07MCNYFY2025 · Dec 31, 2025
Research & Development
122.57MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
55.96MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
6.25MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
2.15MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
5.05MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1100CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1100CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
429.88MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
429.88MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
47.47MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-179.62KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
81.02MCNYFY2025 · Dec 31, 2025
Free Cash Flow
35.26MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
396.41MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
47.47MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
25.05MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-16.59MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
25.10MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-45.77MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-45.77MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
67.40MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-76.50MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-4.19MCNYFY2025 · Dec 31, 2025
Other Financing Charges
3.55MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-9.74MCNYFY2025 · Dec 31, 2025
Shares Outstanding
417.95MSharesUpdated Oct 24, 2026
Float Shares
290.90MSharesUpdated Oct 24, 2026
% Held by Insiders
26.09%
vs all stocks
Updated Oct 24, 2026
% Held by Institutions
4.09%
vs all stocks
Updated Oct 24, 2026
Total Cash (MRQ)
430.32MCNY
64.54M · vs all stocks (USD)
Updated Oct 24, 2026
Total Cash per Share (MRQ)
1.03CNYUpdated Oct 24, 2026
Total Debt (MRQ)
151.32MCNY
22.69M · vs all stocks (USD)
Updated Oct 24, 2026
Total Debt to Equity (MRQ)
0.1411x
vs Medical Devices peers
Updated Oct 24, 2026
Current Ratio (MRQ)
2.67x
vs Medical Devices peers
Updated Oct 24, 2026
Book Value per Share (MRQ)
2.39CNYUpdated Oct 24, 2026
Total Assets
1.35BCNY
202.42M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
520.39MCNYFY2025 · Dec 31, 2025
Total Liabilities
389.84MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
829.28MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
56.09MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
333.75MCNYFY2025 · Dec 31, 2025
Cash
395.41MCNYFY2025 · Dec 31, 2025
Cash Equivalents
1.00MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
396.41MCNYFY2025 · Dec 31, 2025
Accounts Receivable
25.14MCNYFY2025 · Dec 31, 2025
Inventory
88.79MCNYFY2025 · Dec 31, 2025
Accounts Payable
33.03MCNYFY2025 · Dec 31, 2025
Short-term Debt
196.90MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
151.53KCNYFY2025 · Dec 31, 2025
Long-term Debt
14.83MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
416.05MCNYFY2025 · Dec 31, 2025
Retained Earnings
-193.53MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
959.83MCNY
143.95M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
12.84CNYUpdated Oct 24, 2026
52-Week High
28.82CNYUpdated Oct 24, 2026
52-Week Change
-49.82%
vs all stocks
Updated Oct 24, 2026
Beta
0.5950x
vs all stocks
Updated Oct 24, 2026
50-Day MA
15.92CNYUpdated Oct 24, 2026
200-Day MA
19.41CNYUpdated Oct 24, 2026
Avg 10-Day Volume
7.46MSharesUpdated Oct 24, 2026
Avg 30-Day Volume
7.48MSharesUpdated Oct 24, 2026
Diluted EPS (TTM)
0.2000CNYUpdated Oct 24, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.